Literature DB >> 32483035

General Anesthesia Recommendations for Electroconvulsive Therapy During the Coronavirus Disease 2019 Pandemic.

Janine Limoncelli1, Tambudzia Marino2, Roy Smetana3, Pablo Sanchez-Barranco3, Mary Brous3, Kevin Cantwell3, Mark J Russ3, Patricia Fogarty Mack2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32483035      PMCID: PMC7299092          DOI: 10.1097/YCT.0000000000000705

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.692


× No keyword cloud information.
During the coronavirus disease 2019 (COVID-19), pandemic elective surgical cases have been canceled in many institutions to conserve personal protective equipment (PPE) and prevent spread of the virus. It is essential for the medical community to have a full understanding and deep appreciation for the distinctive role of electroconvulsive therapy (ECT) and its colossal value of restoring function and maintaining quality of life. Electroconvulsive therapy is life-saving for many patients with psychosis and/or major depression.[1,2] During this pandemic, it will be necessary for the ECT practitioner, with guidance from professional associations and in collaboration with their available healthcare resources, to develop guidelines focusing on determining the necessity to perform ECT in the safest manner.[2] Early guidance from the Anesthesia Patient Safety Foundation and other sources regarding airway management in COVID-19–positive patients has recommended rapid sequence intubation and avoidance of mask ventilation to reduce the risk of droplet spread and aerosolization of virus.[3] Given the penetrance of COVID-19 in the New York metropolitan area, the Weill Cornell Medicine NewYork-Presbyterian Hospital Anesthesiology and Psychiatry departments collaborated to develop guidelines to ensure that the patients who were in urgent need of ECT were provided that care while minimizing exposure to the staff and potential spread of disease to other ECT patients. The psychiatry department established a review process to confirm that each patient had an urgent need for ECT. The department of anesthesiology decided against repeated intubation and extubation or insertion and removal of supraglottic devices for ECT treatment because these procedures could potentially result in a greater risk of aerosolization than low tidal volume mask ventilation. The dental and oral surgery infection control literature recommends reducing nasopharyngeal viral burden with povidone-iodine nasal swabs and either 1.0% to 1.5% peroxide or 0.2% povidone mouth rinse, because of the susceptibility of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) to oxidizing agents.[4,5] Chlorhexidine is not as effective.[6] Based on this literature, a multifaceted program was developed, the highlights of which are illustrated in Figure 1.
FIGURE 1

Protocol for ECT during COVID-19 pandemic.

Protocol for ECT during COVID-19 pandemic. Before ECT treatment, each patient is screened for symptoms of COVID-19. Povidone-iodine nasal swabs and hydrogen peroxide oral rinsing are performed and have been added to the preprocedure orders on the inpatient unit. A surgical mask is placed on each patient, and the patient performs hand hygiene before leaving the inpatient unit. In the preprocedural area, a maximum of 2 patients are allowed, each separated by 6 ft, and each accompanied by a mental health worker. The preprocedure checklist (Fig. 2) is reconfirmed before each treatment. In the procedure room, all personnel are required to wear PPE including an N-95 respirator mask, surgical mask with face shield, welders-type face shield, isolation gown, and double gloves. Personal protective equipment has been donned under observation by another provider, and an N-95 self-fit test is confirmed. Each patient is asked to insert the bite block into their mouth, and an anesthesia mask with a high-efficiency particulate air (HEPA) filter at the immediate mask outlet is applied and held in place with a head strap. The patient is then preoxygenated while an anesthesia provider inserts a peripheral intravenous (IV). Jackson-Rees circuit is used for oxygen delivery because of the ease of spontaneous ventilation compared with an Ambu bag. The lowest possible inflow of oxygen is selected, typically 2 to 4 L/min. After induction of anesthesia and application of electrical stimulus, positive pressure ventilation is administered at the anesthesiologist's discretion with one practitioner ensuring good seal of the facemask and the other provider delivering low tidal volume ventilation as needed to maintain adequate saturation. Upon return of spontaneous ventilation, the circuit, anesthesia mask, and bite block are removed and placed in a biohazard bag to be discarded. A surgical mask is then placed back on the patient. Doffing of protective gown and gloves and hand hygiene is performed with direct observation. The provider's N-95 mask and surgical mask with face shield remain in place for the day, whereas the welder type face shield is cleaned with sanitizing wipe after each patient. As the patient is transported to the post-anesthesia care unit (PACU) by the anesthesiologist and the psychiatrist, the procedure room is decontaminated by a dedicated team. All staff wear full PPE. Supplemental oxygen is administered via nasal cannula under the surgical facemask only if necessary to maintain O2 saturation above 90%. Upon patient discharge to the floor, the room is decontaminated.
FIGURE 2

Pre-ECT checklist.

Pre-ECT checklist. Several challenges have been encountered in implementing this ECT process. These challenges include the availability of PPE and the need to wear an N95 mask covered by a surgical mask for the duration of the treatment day. In addition, because securing HEPA filters for mask ventilation has been problematic, high-quality heat and moisture exchanger (HME)s have been used in place of HEPA filters when necessary. Facility changes necessary to adapt existing practice have included creating appropriate donning and doffing areas, and visual educational guides have been placed throughout the ECT suite for health care providers to reference. Whereas anesthesia for ECT had been performed by a single anesthesiologist in the past, the donning and doffing of PPE in addition to the necessity of ensuring complete mask fit if positive pressure ventilation is used require 2 anesthesia providers to be available at all times. To maximize adherence to our practice changes and establish familiarity with the unique aspects of each patient, the decision was to use same team of anesthesia providers for ECT during the pandemic. This practice, while ensuring continuity, has been stressful for the clinical team, which provides anesthetic care multiple times a week to a population of patients with a very high potential penetrance of COVID-19. In fact, a few of our patients have developed COVID-19 symptoms and tested positive during their treatment. To this date, our treatment team remains asymptomatic. Although all psychiatric inpatients are required to wear masks at all times and practice social distancing, the structure of communal living on the inpatient unit remains a concern for spread. The current policy now provides for all patients to be tested on admission, and all ECT patients are tested weekly for surveillance. These recommendations can easily be applied to the outpatient community setting for ECT. With the increasing availability of rapid COVID-19 testing, patients can be screened within 24 to 48 hours before their procedures. This extra layer of safety can help prevent the spread of virus within a facility. In addition, N-95 masks can be covered with a surgical mask, enabling the use of the N-95 mask for an entire day or even up to a week if it is also protected with the welder type face shield. Developing a team-oriented approach for practicing and observing donning and doffing PPE, maintaining social distance as much as possible between both staff and patients, and being deliberate about decontaminating areas with appropriate quaternary ammonium/isopropyl alcohol/hydrogen peroxide wipes are feasible in the outpatient setting and incorporate low-cost steps to ensure the safe performance of ECT during the COVID-19 pandemic. With respect to airway management of the patient during general anesthesia for ECT, we prefer the Jackson-Rees circuit over the bag-mask ventilation. The Jackson-Rees circuit in general is less expensive than the bag-mask ventilation, and in addition, it allows better control of the pressure that is transmitted to the patient's respiratory tract. The most challenging aspect of the airway management in the outpatient setting, with respect to our recommendations, is the provision of a second anesthesia clinician to ensure a tight mask fit to minimize and avoid droplet or aerosol transmission of the virus. To this end, it would be reasonable and acceptable for the anesthesiologist to train a second clinical provider in the ECT suite, such as an registered nurse (RN), physician assistant (PA), nurse practitioner (NP), and the psychiatrist, to assist with securing a tight mask fit. Future decisions regarding the need for and frequency of surveillance testing of inpatients as well as determining at what time COVID-19–positive patients may return to the ECT suite to continue their treatment will be reached via collaboration among the departments of anesthesiology, psychiatry, and infection prevention and control.
  4 in total

1.  The role of ECT in suicide prevention.

Authors:  Max Fink; Charles H Kellner; W Vaughn McCall
Journal:  J ECT       Date:  2014-03       Impact factor: 3.635

Review 2.  Transmission routes of 2019-nCoV and controls in dental practice.

Authors:  Xian Peng; Xin Xu; Yuqing Li; Lei Cheng; Xuedong Zhou; Biao Ren
Journal:  Int J Oral Sci       Date:  2020-03-03       Impact factor: 6.344

Review 3.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Authors:  G Kampf; D Todt; S Pfaender; E Steinmann
Journal:  J Hosp Infect       Date:  2020-02-06       Impact factor: 3.926

4.  Electroconvulsive Therapy During COVID-19: An Essential Medical Procedure-Maintaining Service Viability and Accessibility.

Authors:  Randall T Espinoza; Charles H Kellner; William V McCall
Journal:  J ECT       Date:  2020-06       Impact factor: 3.635

  4 in total
  7 in total

1.  Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National Survey.

Authors:  Ilya Demchenko; Daniel M Blumberger; Alastair J Flint; Melanie Anderson; Zafiris J Daskalakis; Karen Foley; Keyvan Karkouti; Sidney H Kennedy; Karim S Ladha; Jamie Robertson; Alon Vaisman; David Koczerginski; Sagar V Parikh; Venkat Bhat
Journal:  J ECT       Date:  2022-03-01       Impact factor: 3.692

Review 2.  Anesthetic care for electroconvulsive therapy.

Authors:  Kyoung-Woon Joung; Dong Ho Park; Chang Young Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-15

3.  Ethical Considerations in Providing Electroconvulsive Therapy during the COVID-19 Pandemic.

Authors:  Jamie Robertson; Alastair J Flint; Daniel Blumberger; Venkat Bhat
Journal:  Can J Psychiatry       Date:  2021-02-18       Impact factor: 4.356

4.  The Interface of COVID-19 and Inpatient Psychiatry: Our Experience and Lessons Learned.

Authors:  Mark J Russ; Sharon J Parish; Ruth Mendelowitz; Shayne Mendoza; Stan D Arkow; Michael Radosta; Linda Espinosa; Lisa B Sombrotto; Donna Anthony; David A Wyman; Lourival Baptista-Neto; Philip J Wilner
Journal:  J Psychiatr Pract       Date:  2021-05-05       Impact factor: 1.841

Review 5.  A Comprehensive Overview of the COVID-19 Literature: Machine Learning-Based Bibliometric Analysis.

Authors:  Alaa Abd-Alrazaq; Jens Schneider; Borbala Mifsud; Tanvir Alam; Mowafa Househ; Mounir Hamdi; Zubair Shah
Journal:  J Med Internet Res       Date:  2021-03-08       Impact factor: 5.428

6.  Psychotropics and COVID-19: An analysis of safety and prophylaxis.

Authors:  H Javelot; C Straczek; G Meyer; C Gitahy Falcao Faria; L Weiner; D Drapier; E Fakra; P Fossati; S Weibel; S Dizet; B Langrée; M Masson; R Gaillard; M Leboyer; P M Llorca; C Hingray; E Haffen; A Yrondi
Journal:  Encephale       Date:  2021-09-02       Impact factor: 1.291

Review 7.  The Impact of COVID-19 on Brain Stimulation Therapy.

Authors:  Michael Justin Coffey; Suzanne Kerns; Sohag Sanghani; Lee Wachtel
Journal:  Psychiatr Clin North Am       Date:  2021-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.